• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲状腺状态改变时的氧化应激与心力衰竭

Oxidative stress and heart failure in altered thyroid States.

作者信息

Mishra Pallavi, Samanta Luna

机构信息

Department of Zoology, Utkal University, Odisha, Bhubaneswar 751004, India.

出版信息

ScientificWorldJournal. 2012;2012:741861. doi: 10.1100/2012/741861. Epub 2012 May 2.

DOI:10.1100/2012/741861
PMID:22649319
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3354657/
Abstract

Increased or reduced action of thyroid hormone on certain molecular pathways in the heart and vasculature causes relevant cardiovascular derangements. It is well established that hyperthyroidism induces a hyperdynamic cardiovascular state, which is associated with a faster heart rate, enhanced left ventricular systolic and diastolic function whereas hypothyroidism is characterized by the opposite changes. Hyperthyroidism and hypothyroidism represent opposite clinical conditions, albeit not mirror images. Recent experimental and clinical studies have suggested the involvement of ROS tissue damage under altered thyroid status. Altered-thyroid state-linked changes in heart modify their susceptibility to oxidants and the extent of the oxidative damage they suffer following oxidative challenge. Chronic increase in the cellular levels of ROS can lead to a catastrophic cycle of DNA damage, mitochondrial dysfunction, further ROS generation and cellular injury. Thus, these cellular events might play an important role in the development and progression of myocardial remodeling and heart failure in altered thyroid states (hypo- and hyper-thyroidism). The present review aims at elucidating the various signaling pathways mediated via ROS and their modulation under altered thyroid state and the possibility of antioxidant therapy.

摘要

甲状腺激素对心脏和血管某些分子途径的作用增强或减弱会导致相关的心血管紊乱。众所周知,甲状腺功能亢进会诱发高动力性心血管状态,这与心率加快、左心室收缩和舒张功能增强有关,而甲状腺功能减退则表现为相反的变化。甲状腺功能亢进和减退代表了相反的临床状况,尽管并非镜像关系。最近的实验和临床研究表明,甲状腺状态改变时会发生活性氧(ROS)介导的组织损伤。甲状腺状态改变导致的心脏变化会改变其对氧化剂的敏感性以及氧化应激挑战后所遭受的氧化损伤程度。细胞内ROS水平的长期升高会导致DNA损伤、线粒体功能障碍、进一步的ROS生成和细胞损伤的灾难性循环。因此,这些细胞事件可能在甲状腺状态改变(甲状腺功能减退和亢进)时心肌重塑和心力衰竭的发生及发展中起重要作用。本综述旨在阐明ROS介导的各种信号通路及其在甲状腺状态改变时的调节作用以及抗氧化治疗的可能性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa58/3354657/8e1a6c67bfa8/TSWJ2012-741861.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa58/3354657/8d78d9a8b856/TSWJ2012-741861.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa58/3354657/b5bd73b1f769/TSWJ2012-741861.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa58/3354657/8e1a6c67bfa8/TSWJ2012-741861.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa58/3354657/8d78d9a8b856/TSWJ2012-741861.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa58/3354657/b5bd73b1f769/TSWJ2012-741861.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa58/3354657/8e1a6c67bfa8/TSWJ2012-741861.003.jpg

相似文献

1
Oxidative stress and heart failure in altered thyroid States.甲状腺状态改变时的氧化应激与心力衰竭
ScientificWorldJournal. 2012;2012:741861. doi: 10.1100/2012/741861. Epub 2012 May 2.
2
Effects of thyroid hormone on the cardiovascular system.甲状腺激素对心血管系统的影响。
Recent Prog Horm Res. 2004;59:31-50. doi: 10.1210/rp.59.1.31.
3
Thyroid hormone and the cardiovascular system.甲状腺激素与心血管系统。
N Engl J Med. 2001 Feb 15;344(7):501-9. doi: 10.1056/NEJM200102153440707.
4
Effect of thyroid state on susceptibility to oxidants and swelling of mitochondria from rat tissues.甲状腺状态对大鼠组织线粒体对氧化剂的敏感性及肿胀的影响。
Free Radic Biol Med. 2003 Sep 1;35(5):485-94. doi: 10.1016/s0891-5849(03)00331-9.
5
Oxidative stress and heart failure.氧化应激与心力衰竭。
Am J Physiol Heart Circ Physiol. 2011 Dec;301(6):H2181-90. doi: 10.1152/ajpheart.00554.2011. Epub 2011 Sep 23.
6
[Role of oxidative stress in heart failure].[氧化应激在心力衰竭中的作用]
Nihon Rinsho. 2003 May;61(5):756-60.
7
Mitochondrial oxidative stress and heart failure.线粒体氧化应激与心力衰竭
Intern Med. 2006;45(13):809-13. doi: 10.2169/internalmedicine.45.1765. Epub 2006 Aug 1.
8
Effects of experimentally induced maternal hypothyroidism and hyperthyroidism on the development of rat offspring: II-the developmental pattern of neurons in relation to oxidative stress and antioxidant defense system.实验性诱导的母体甲状腺功能减退和甲状腺功能亢进对大鼠后代发育的影响:II-与氧化应激和抗氧化防御系统相关的神经元发育模式
Int J Dev Neurosci. 2012 Oct;30(6):517-37. doi: 10.1016/j.ijdevneu.2012.04.005. Epub 2012 Jun 1.
9
[Thyrometabolic disorders and heart failure].[甲状腺代谢紊乱与心力衰竭]
Endokrynol Pol. 2007 May-Jun;58(3):228-35.
10
Thyroid hormones and heart failure.甲状腺激素与心力衰竭
Heart Fail Rev. 2016 Jul;21(4):361-4. doi: 10.1007/s10741-016-9556-5.

引用本文的文献

1
Impairment of Left Ventricular Function in Hyperthyroidism Caused by Graves' Disease: An Echocardiographic Study.格雷夫斯病所致甲状腺功能亢进症患者左心室功能损害:一项超声心动图研究
J Clin Med. 2024 Dec 2;13(23):7348. doi: 10.3390/jcm13237348.
2
Sacubitril/valsartan in Heart Failure and Beyond-From Molecular Mechanisms to Clinical Relevance.沙库巴曲缬沙坦在心力衰竭及其他方面——从分子机制到临床意义
Rev Cardiovasc Med. 2022 Jun 24;23(7):238. doi: 10.31083/j.rcm2307238. eCollection 2022 Jul.
3
Cardiac manifestations in hyperthyroidism.甲状腺功能亢进症的心脏表现。

本文引用的文献

1
Excessive thyroxine enhances susceptibility to apoptosis and decreases contractility of cardiomyocytes.甲状腺素过量会增强心肌细胞对细胞凋亡的敏感性,并降低其收缩力。
Mol Cell Endocrinol. 2010 May 14;320(1-2):67-75. doi: 10.1016/j.mce.2010.01.031. Epub 2010 Feb 1.
2
Angiotensin type 1 receptor mediates thyroid hormone-induced cardiomyocyte hypertrophy through the Akt/GSK-3beta/mTOR signaling pathway.血管紧张素1型受体通过Akt/GSK-3β/mTOR信号通路介导甲状腺激素诱导的心肌细胞肥大。
Basic Res Cardiol. 2009 Nov;104(6):653-67. doi: 10.1007/s00395-009-0043-1. Epub 2009 Jul 9.
3
Impact of oxypurinol in patients with symptomatic heart failure. Results of the OPT-CHF study.
Rev Cardiovasc Med. 2022 Apr 11;23(4):136. doi: 10.31083/j.rcm2304136. eCollection 2022 Apr.
4
IL-38 attenuates myocardial ischemia-reperfusion injury by inhibiting macrophage inflammation.IL-38 通过抑制巨噬细胞炎症来减轻心肌缺血再灌注损伤。
Immun Inflamm Dis. 2023 Jun;11(6):e898. doi: 10.1002/iid3.898.
5
Mechanisms and Management of Thyroid Disease and Atrial Fibrillation: Impact of Atrial Electrical Remodeling and Cardiac Fibrosis.甲状腺疾病与心房颤动的机制与管理:心房电重构与心肌纤维化的影响。
Cells. 2022 Dec 14;11(24):4047. doi: 10.3390/cells11244047.
6
Increased Mitochondrial DNA Copy Number and Oxidative Damage in Patients with Hashimoto's Thyroiditis.桥本甲状腺炎患者线粒体DNA拷贝数增加及氧化损伤
Iran J Public Health. 2021 Aug;50(8):1697-1704. doi: 10.18502/ijph.v50i8.6817.
7
Acute myocarditis in bodybuilder from coxsackievirus and thyrotoxicosis.一名健美运动员由柯萨奇病毒和甲状腺毒症引发的急性心肌炎。
J Cardiol Cases. 2016 Jul 20;14(4):123-126. doi: 10.1016/j.jccase.2016.06.005. eCollection 2016 Oct.
8
[Activation of aldehyde dehydrogenase 2 alleviates H O -induced injury in cardiomyocytes].醛脱氢酶2的激活减轻过氧化氢诱导的心肌细胞损伤
Nan Fang Yi Ke Da Xue Xue Bao. 2018 Jul 30;38(8):938-942. doi: 10.3969/j.issn.1673-4254.2018.08.06.
9
Calenduloside E Analogues Protecting H9c2 Cardiomyocytes Against HO-Induced Apoptosis: Design, Synthesis and Biological Evaluation.金盏花苷E类似物对HO诱导的H9c2心肌细胞凋亡的保护作用:设计、合成及生物学评价
Front Pharmacol. 2017 Nov 23;8:862. doi: 10.3389/fphar.2017.00862. eCollection 2017.
10
Clozapine-induced cardiotoxicity in rats: Involvement of tumour necrosis factor alpha, NF-κβ and caspase-3.氯氮平诱导大鼠心脏毒性:肿瘤坏死因子α、核因子κB和半胱天冬酶-3的作用
Toxicol Rep. 2014 Nov 20;1:1213-1223. doi: 10.1016/j.toxrep.2014.11.012. eCollection 2014.
氧嘌呤醇对有症状心力衰竭患者的影响。OPT-CHF研究结果。
J Am Coll Cardiol. 2008 Jun 17;51(24):2301-9. doi: 10.1016/j.jacc.2008.01.068.
4
Upregulation of AT2 receptor and iNOS impairs angiotensin II-induced contraction without endothelium influence in young normotensive diabetic rats.在年轻的血压正常的糖尿病大鼠中,AT2受体和诱导型一氧化氮合酶的上调在无内皮影响的情况下削弱了血管紧张素II诱导的收缩。
Am J Physiol Regul Integr Comp Physiol. 2008 Jul;295(1):R144-54. doi: 10.1152/ajpregu.00191.2008. Epub 2008 May 7.
5
Edaravone (3-methyl-1-phenyl-2-pyrazolin-5-one), a novel free radical scavenger, for treatment of cardiovascular diseases.依达拉奉(3-甲基-1-苯基-2-吡唑啉-5-酮),一种新型自由基清除剂,用于治疗心血管疾病。
Recent Pat Cardiovasc Drug Discov. 2006 Jan;1(1):85-93. doi: 10.2174/157489006775244191.
6
Rosuvastatin in older patients with systolic heart failure.老年收缩性心力衰竭患者使用瑞舒伐他汀的情况
N Engl J Med. 2007 Nov 29;357(22):2248-61. doi: 10.1056/NEJMoa0706201. Epub 2007 Nov 5.
7
Mechanisms of nongenomic actions of thyroid hormone.甲状腺激素非基因组作用的机制。
Front Neuroendocrinol. 2008 May;29(2):211-8. doi: 10.1016/j.yfrne.2007.09.003. Epub 2007 Oct 5.
8
Metabolic profile of nebivolol, a beta-adrenoceptor antagonist with unique characteristics.奈必洛尔的代谢概况,一种具有独特特性的β-肾上腺素能受体拮抗剂。
Drugs. 2007;67(8):1097-107. doi: 10.2165/00003495-200767080-00001.
9
Potential role and mechanisms of subcellular remodeling in cardiac dysfunction due to ischemic heart disease.亚细胞重塑在缺血性心脏病所致心脏功能障碍中的潜在作用及机制
J Cardiovasc Med (Hagerstown). 2007 Apr;8(4):238-50. doi: 10.2459/01.JCM.0000263489.13479.68.
10
Time-dependent changes in the expression of thyroid hormone receptor alpha 1 in the myocardium after acute myocardial infarction: possible implications in cardiac remodelling.急性心肌梗死后心肌中甲状腺激素受体α1表达的时间依赖性变化:对心脏重塑的可能影响
Eur J Endocrinol. 2007 Apr;156(4):415-24. doi: 10.1530/EJE-06-0707.